New developments in the pathology of malignant lymphoma: A review of the literature published from May to July 2008

Journal of Hematopathology

Volumn 1, Issue 2, 2008, Pages 145-160

  van Krieken, J Han ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84880620922     PISSN: None     EISSN: 18655785     Source Type: Journal    
DOI: 10.1007/s12308-008-0012-x     Document Type: Review

References (79)

1. Ma Y, Visser L, Blokzijl T, Harms G, Atayar C, Poppema S, van den Berg A (2008) The CD4+CD26-T-cell population in classical Hodgkin's lymphoma displays a distinctive regulatory Tcell profile. Lab Invest 88:482-490
2. Nie K, Gomez M, Landgraf P, Garcia JF, Liu Y, Tan LH, Chadburn A, Tuschl T, Knowles DM, Tam W (2008) Micro RNA mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas. Am J Pathol 173:242-252
3. Rodig SJ, Ouyang J, Juszczynski P, Currie T, Law K, Neuberg DS, Rabinovich GA, Shipp MA, Kutok JL (2008) AP1-dependent galectin-1 expression delineates classical Hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features. Clin Cancer Res 14:3338-3344
4. van Krieken J Han JM (2008) New developments in the pathology of malignant lymphoma: a review of the literature published from January to April 2008. J Hematopathol 1:37-45
5. Yang C, Lu P, Lee FY, Chadburn A, Barrientos JC, Leonard JP, Ye F, Zhang D, Knowles DM, Wang YL (2008) Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinib. Leukemia (in press)
6. Kim YS, Seo DW, Kong SK, Lee JH, Lee ES, Stetler-Stevenson M, Stetler-Stevenson WG (2008) TIMP1 induces CD44 expression and the activation and nuclear translocation of SHP1 during the late centrocyte/post-germinal center B cell differentiation. Cancer Lett (in press)
7. Garrison SP, Jeffers JR, Yang C, Nilsson JA, Hall MA, Rehg JE, Yue W, Yu J, Zhang L, Onciu M, Sample JT, Cleveland JL, Zambetti GP (2008) Selection against PUMA gene expression in Myc-driven B cell lymphomagenesis. Mol Cell Biol (in press)
8. Nyagol J, De Falco G, Lazzi S, Luzzi A, Cerino G, Shaheen S, Palummo N, Bellan C, Spina D, Leoncini L (2008) HIV-1 Tat mimetic of VEGF correlates with increased microvessels density in AIDS-related diffuse large B-cell and Burkitt lymphomas. J Hematopathol 1:3-10
9. Larson A, Cook JR (2008) Fibroblast growth factor receptor 3 (FGFR3) expression in malignant lymphomas. Appl Immunohistochem Mol Morphol 16:322-325
10. Goatly A, Bacon CM, Nakamura S, Ye H, Kim I, Brown PJ, Ruskoné-Fourmestraux A, Cervera P, Streubel B, Banham AH, Du MQ (2008) FOXP1 abnormalities in lymphoma: translocation breakpoint mapping reveals insights into deregulated transcriptional control. Mod Pathol 21:902-911
11. Hogan C, Hutchison C, Marcar L, Milne D, Saville M, Goodlad J, Kernohan N, Meek D (2008) Elevated levels of oncogenic protein kinase Pim-1 induce the p53 pathway in cultured cells and correlate with increased Mdm2 in mantle cell lymphoma. J Biol Chem 283:18012-18023
12. Dal Col J, Zancai P, Terrin L, Guidoboni M, Ponzoni M, Pavan A, Spina M, Bergamin S, Rizzo S, Tirelli U, De Rossi A, Doglioni C, Dolcetti R (2008) Distinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma. Blood 111:5142-5151
13. Wang M, Zhang L, Han X, Yang J, Qian J, Hong S, Lin P, Shi Y, Romaguera J, Kwak LW, Yi Q (2008) A severe combined immunodeficient-hu in vivo mouse model of human primary mantle cell lymphoma. Clin Cancer Res 14:2154-2160
14. Giatromanolaki A, Koukourakis MI, Pezzella F, Sivridis E, Turley H, Harris AL, Gatter KC (2008) Phosphorylated VEGFR2/KDR receptors are widely expressed in B-cell non-Hodgkin's lymphomas and correlate with hypoxia inducible factor activation. Hematol Oncol (in press)
15. Thielen C, Radermacher V, Trimeche M, Roufosse F, Goldman M, Boniver J, de Leval L (2008) TARC and IL-5 expression correlates with tissue eosinophilia in peripheral T-cell lymphomas. Leuk Res 32:1431-1438
16. Feldman AL, Sun DX, Law ME, Novak AJ, Attygalle AD, Thorland EC, Fink SR, Vrana JA, Caron BL, Morice WG, Remstein ED, Grogg KL, Kurtin PJ, Macon WR, Dogan A (2008) Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas. Leukemia 6:1139-1143
17. Bonzheim I, Geissinger E, Chuang Wen-Yu, Roth S, Ströbel P, Marx A, Reimer P, Wilhelm M, Puppe B, Rosenwald A, Müller-Hermelink HK, Rüdiger T (2008) Analysis of single nucleotide polymorphisms in the FAS and CTLA-4 genes of peripheral T-cell lymphomas. J Hematopathol 1:11-21
18. Bard JD, Gelebart P, Anand M, Amin HM, Lai R (2008) Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK(+) anaplastic large cell lymphoma. Leukemia (in press)
19. Vermeer MH, van Doorn R, Dijkman R, Mao X, Whittaker S, van Voorst Vader PC, Gerritsen MJ, Geerts ML, Gellrich S, Söderberg O, Leuchowius KJ, Landegren U, Out-Luiting JJ, Knijnenburg J, Ijszenga M, Szuhai K, Willemze R, Tensen CP (2008) Novel and highly recurrent chromosomal alterations in Sézary syndrome. Cancer Res 68:2689-2698
20. Gjerdrum LM, Woetmann A, Odum N, Hother C, Henrik-Nielsen R, Gniadecki R, Ralfkiaer E (2008) FOXP3 positive regulatory T-cells in cutaneous and systemic CD30 positive T-cell lymphoproliferations. Eur J Haematol 80:483-489
21. Chabay PA, Barros MH, Hassan R, De Matteo E, Rey G, Carrico MK, Renault IZ, Preciado MV (2008) Pediatric Hodgkin lymphoma in 2 South American series: a distinctive epidemiologic pattern and lack of association of Epstein-Barr virus with clinical outcome. J Pediatr Hematol Oncol 30:285-291
22. Pulte D, Gondos A, Brenner H (2008) Ongoing improvement in outcomes for patients diagnosed as having non-Hodgkin lymphoma from the 1990s to the early 21st century. Arch Intern Med 168:469-476
23. Andrews CN, John Gill M, Urbanski SJ, Stewart D, Perini R, Beck P (2008) Changing epidemiology and risk factors for gastrointestinal non-Hodgkin's Lymphoma in a North American population: population-based study. Am J Gastroenterol (in press)
24. Mwakigonja AR, Kaaya EE, Mgaya EM (2008) Malignant lymphomas (ML) and HIV infection in Tanzania. J Exp Clin Cancer Res 27:9
25. Tumwine LK, Campidelli C, Righi S, Neda S, Byarugaba W, Pileri SA (2008) B-cell non-Hodgkin lymphomas in Uganda: an immunohistochemical appraisal on tissue microarray. Hum Pathol 9:817-823
26. Cho EY, Kim KH, Kim WS, Yoo KH, Koo HH, Ko YH (2008) The spectrum of Epstein-Barr virus-associated lymphoproliferative disease in Korea: incidence of disease entities by age groups. J Korean Med Sci 23:185-192
27. Sjo LD, Ralfkiaer E, Prause JU, Petersen JH, Madsen J, Pedersen NT, Heegaard S (2008) Increasing incidence of ophthalmic lymphoma in Denmark from 1980 to 2005. Invest Ophthalmol Vis Sci 49:3283-3288
28. Nam-Cha SH, Roncador G, Sanchez-Verde L, Montes-Moreno S, Acevedo A, Domínguez-Franjo P, Piris MA (2008) PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma. Am J Surg Pathol 32:1252-1257
29. Xerri L, Chetaille B, Seriari N, Attias C, Guillaume Y, Arnoulet C, Olive D (2008) Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/ chronic lymphocytic leukemia. Hum Pathol 39:1050-1058
30. Klapper W, Szczepanowski M, Burkhardt B, Berger H, Rosolowski M, Bentink S, Schwaenen C, Wessendorf S, Spang R, Moller P, Hansmann ML, Bernd HW, Ott G, Hummel M, Stein H, Loeffler M, Trumper L, Zimmermann M, Reiter A, Siebert R (2008) Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials. Blood (in press)
31. Karube K, Ying G, Tagawa H, Niino D, Aoki R, Kimura Y, Hashikawa K, Suefuji N, Sugita Y, Nomura Y, Shimizu K, Yoshida S, Seto M, Ohshima K (2008) BCL6 gene amplification/ 3q27 gain is associated with unique clinicopathological characteristics among follicular lymphoma without BCL2 gene translocation. Mod Pathol 21:973-978
32. Piccaluga PP, Califano A, Klein U, Agostinelli C, Bellosillo B, Gimeno E, Serrano S, Solè F, Zang Y, Falini B, Zinzani PL, Pileri SA (2008) Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas. Haematologica 93:1033-1038
33. Martinez A, Pittaluga S, Rudelius M, Davies-Hill T, Sebasigari D, Fountaine TJ, Hewitt S, Jaffe ES, Raffeld M (2008) Expression of the interferon regulatory factor 8/ICSBP-1 in human reactive lymphoid tissues and b-cell lymphomas: a novel germinal center marker. Am J Surg Pathol 32:1190-1200
34. Baecklund E, Natkunam Y, Backlin C, Iliadou A, Askling J, Ekbom A, Feltelius N, Klareskog L, Enblad G, Lossos IS, Levy R, Sundström C, Rosenquist R (2008) Expression of the human germinal-centre-associated lymphoma protein in diffuse large Bcell lymphomas in patients with rheumatoid arthritis. Br J Haematol 141:69-72
35. Barone F, Bombardieri M, Rosado MM, Morgan PR, Challacombe SJ, De Vita S, Carsetti R, Spencer J, Valesini G, Pitzalis C (2008) CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjogren's syndrome and MALT lymphoma: association with reactive and malignant areas of lymphoid organization. J Immunol 180:5130-5140
36. Nakamura S, Ye H, Bacon CM, Goatly A, Liu H, Kerr L, Banham AH, Streubel B, Yao T, Tsuneyoshi M, Savio A, Takeshita M, Dartigues P, Ruskoné-Fourmestraux A, Matsumoto T, Iida M, Du MQ (2008) Translocations involving the immunoglobulin heavy chain gene locus predict better survival in gastric diffuse large Bcell lymphoma. Clin Cancer Res 14:3002-3010
37. Wang M, Tan LP, Dijkstra MK, van Lom K, Robertus JL, Harms G, Blokzijl T, Kooistra K, van T'veer MB, Rosati S, Visser L, Jongen-Lavrencic M, Kluin PM, van den Berg A (2008) miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression. J Pathol 215:13-20
38. Lima FP, Bousquet M, Gomez-Brouchet A, de Paiva GR, Amstalden EM, Soares FA, Dastugue N, Vassallo J, Brousset P (2008) Primary diffuse large B-cell lymphoma of bone displays preferential rearrangements of the c-MYC or BCL2 gene. Am J Clin Pathol 129:723-726
39. Courts C, Montesinos-Rongen M, Brunn A, Bug S, Siemer D, Hans V, Blümcke I, Klapper W, Schaller C, Wiestler OD, Küppers R, Siebert R, Deckert M (2008) Recurrent inactivation of the PRDM1 gene in primary central nervous system lymphoma. J Neuropathol Exp Neurol 67:720-727
40. Demasi A, Magalhães M, Furuse C, Araújo N, Junqueira J, Araújo V (2008) Peroxiredoxin I is differentially expressed in multiple myelomas and in plasmablastic lymphomas. Oral Dis (in press)
41. Klapper W, Böhm M, Siebert R, Lennert K (2008) Morphological variability of lymphohistiocytic variant of anaplastic large cell lymphoma (former lymphohistiocytic lymphoma according to the Kiel classification). Virchows Arch 452(6):599-605
42. de Mascarel A, Belleannée G, Stanislas S, Merlio C, Parrens M, Laharie D, Dubus P, Merlio JP (2008) Mucosal intraepithelial T-lymphocytes in refractory celiac disease: a neoplastic population with a variable CD8 phenotype. Am J Surg Pathol 32:744-751
43. van Galen J, Hoefnagel J, Vermeer M, Willemze R, Dijkman R, Tensen C, de Boer W, Meijer C, Oudejans J (2008) Profiling of apoptosis genes identifies distinct types of primary cutaneous large B cell lymphoma. J Pathol 215:340-346
44. Yamauchi A, Ikeda J, Nakamichi I, Kohara M, Fukuhara S, Hino M, Kanakura Y, Ogawa H, Sugiyama H, Kanamaru A, Aozasa K, Osaka Lymphoma Study Group (2008) Diffuse large B-cell lymphoma showing an interfollicular pattern of proliferation: a study of the Osaka Lymphoma Study Group. Histopathology 52:731-737
45. Cerroni L, Massone C, Kutzner H, Mentzel T, Umbert P, Kerl H (2008) Intravascular large T-cell or NK-cell lymphoma: a rare variant of intravascular large cell lymphoma with frequent cytotoxic phenotype and association with Epstein-Barr virus infection. Am J Surg Pathol 32:891-898
46. Cheuk W, Yuen HK, Chu SY, Chiu EK, Lam LK, Chan JK (2008) Lymphadenopathy of IgG4-related sclerosing disease. Am J Surg Pathol 32:671-681
47. Cheuk W, Yuen HK, Chan AC, Shih LY, Kuo TT, Ma MW, Lo YF, Chan WK, Chan JK (2008) Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of igg4-related sclerosing disease. Am J Surg Pathol 32:1159-1167
48. Kojima M, Miyawaki S, Takada S, Kashiwabara K, Igarashi T, Nakamura S (2008) Lymphoplasmacytic infiltrate of regional lymph nodes in Kuttner's tumor (chronic sclerosing sialadenitis): a report of 3 cases. Int J Surg Pathol 16:263-268
49. Farris AB, Lauwers GY, Ferry JA, Zukerberg LR (2008) The rectal tonsil: a reactive lymphoid proliferation that may mimic lymphoma. Am J Surg Pathol 32:1075-1079
50. Barna G, Reiniger L, Tátrai P, Kopper L, Matolcsy A (2008) The cut-off levels of CD23 expression in the differential diagnosis of MCL and CLL. Hematol Oncol (in press)
51. Inamdar KV, Medeiros LJ, Jorgensen JL, Amin HM, Schlette EJ (2008) Bone marrow involvement by marginal zone B-cell lymphomas of different types. Am J Clin Pathol 129:714-722
52. Holanda D, Zhao MY, Rapoport AP, Garofalo M, Chen Q, Zhao XF (2008) Primary gastric T cell lymphoma mimicking marginal zone B cell lymphoma of mucosa-associated lymphoid tissue. J Hematopathol 1:29-35
53. Hurford MT, Altman AJ, DiGiuseppe JA, Sherburne BJ, Rezuke WN (2008) Unique pattern of nuclear TdT immunofluorescence distinguishes normal precursor B cells (hematogones) from lymphoblasts of precursor B-lymphoblastic leukemia. Am J Clin Pathol 129:700-705
54. Werner B, Massone C, Kerl H, Cerroni L (2008) Large CD30-positive cells in benign, atypical lymphoid infiltrates of the skin. J Cutan Pathol (in press)
55. Porter AB, Giannini C, Kaufmann T, Lucchinetti CF, Wu W, Decker PA, Atkinson JL, O'Neill BP (2008) Primary central nervous system lymphoma can be histologically diagnosed after previous corticosteroid use: a pilot study to determine whether corticosteroids prevent the diagnosis of primary central nervous system lymphoma. Ann Neurol 63:662-667
56. Viny AD, Lichtin A, Pohlman B, Loughran T, Maciejewski J (2008) Chronic B-cell dyscrasias are an important clinical feature of T-LGL leukemia. Leuk Lymphoma 49:932-938
57. Adams H, Schmid P, Dirnhofer S, Tzankov A (2008) Cytokeratin expression in hematological neoplasms: a tissue microarray study on 866 lymphoma and leukemia cases. Pathol Res Pract 204:569-573
58. Baak U, Gökbuget N, Orawa H, Schwartz S, Hoelzer D, Thiel E, Burmeister T (2008) German Multicenter ALL Study Group. Thymic adult T-cell acute lymphoblastic leukemia stratified in standard-and high-risk group by aberrant HOX11L2 expression: experience of the German multicenter ALL study group. Leukemia 22:1154-1160
59. Yamamoto H, Nakamura T, Matsuo K, Tajika M, Kawai H, Ohmiya N, Niwa Y, Goto H, Nakamura S (2008) Significance of CXCR3 expression in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type for predicting responsiveness to Helicobacter pylori eradication. Cancer Sci (in press)
60. Hartmann E, Fernàndez V, Moreno V, Valls J, Hernández L, Bosch F, Abrisqueta P, Klapper W, Dreyling M, Hoster E, Müller-Hermelink HK, Ott G, Rosenwald A, Campo E (2008) Five-gene model to predict survival in mantle-cell lymphoma using frozen or formalin-fixed, paraffin-embedded tissue. J Clin Oncol (in press)
61. Uccella S, Placidi C, Marchet S, Cergnul M, Proserpio I, Chini C, Novario R, Pinotti G, Capella C (2008) Bcl-6 protein expression, and not the germinal centre immunophenotype, predicts favourable prognosis in a series of primary nodal diffuse large B-cell lymphomas: a single centre experience. Leuk Lymphoma 49: 1321-1328
62. Katzenberger T, Kienle D, Stilgenbauer S, Höller S, Schilling C, Mäder U, Puppe B, Petzoldt C, Sander S, Bullinger L, Stöcklein H, Kalla J, Hartmann E, Adam P, Ott MM, Müller-Hermelink HK, Rosenwald A, Ott G (2008) Delineation of distinct tumour profiles in mantle cell lymphoma by detailed cytogenetic, interphase genetic and morphological analysis. Br J Haematol (in press)
63. Zanetto U, Dong H, Huang Y, Zhang K, Narbaitz M, Sapia S, Kostopoulos I, Liu H, Du MQ, Bacon CM (2008) Mantle cell lymphoma with aberrant expression of CD10. Histopathology 53:20-29
64. Young KH, Leroy K, Moller MB, Colleoni GW, Sanchez-Beato M, Kerbauy FR, Haioun C, Eickhoff JC, Young AH, Gaulard P, Piris MA, Oberley TD, Rehrauer WM, Kahl BS, Malter JS, Campo E, Delabie J, Gascoyne RD, Rosenwald A, Rimsza L, Huang J, Braziel RM, Jaffe ES, Wilson WH, Staudt LM, Vose JM, Chan WC, Weisenburger DD, Greiner TC (2008) Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study. Blood (in press)
65. Liu YH, Xu FP, Zhuang HG, Lai KC, Xie D, Luo DL, Li L, Luo XL, Xu J, Zhang MH, Zhang F, Li HM (2008) Clinicopathologic significance of immunophenotypic profiles related to germinal center and activation B-cell differentiation in diffuse large B-cell lymphoma from Chinese patients. Hum Pathol 39:875-884
66. Rimsza LM, Leblanc ML, Unger JM, Miller TP, Grogan TM, Persky DO, Martel RR, Sabalos CM, Seligmann B, Braziel RM, Campo E, Rosenwald A, Connors JM, Sehn LH, Johnson N, Gascoyne RD (2008) Gene expression predicts overall survival in paraffin embedded tissues of diffuse large B cell lymphoma treated with R-CHOP. Blood (in press)
67. Ataollahi M, Salehi M, Doostan I, Kabiri Z, Mohajeri M, Mahmoodi F, Shokouhi R, Javan S, Meshkibaf MH, Miladpoor B (2008) Bcl-2 associated athanogene-1 overexpression in diffuse large B-cell lymphoma. Iran J Immunol 5:124-130
68. Roehle A, Hoefig KP, Repsilber D, Thorns C, Ziepert M, Wesche KO, Thiere M, Loeffler M, Klapper W, Pfreundschuh M, Matolcsy A, Bernd HW, Reiniger L, Merz H, Feller AC (2008) MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas. Br J Haematol (in press)
69. Wang F, Xu RH, Luo HY, Zhang DS, Jiang WQ, Huang HQ, Sun XF, Xia ZJ, Guan ZZ (2008) Clinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma. BMC Cancer 8:115
70. Xiang-Lan M, Zu-Lan S, Dan H, Bi-Hong S, Ya-Qin P, Han-Liang L (2008) Skp2/p27 expression profile is correlated with Epstein-Barr virus status in extranodal nasal-type natural killer cell lymphoma. Transl Res 151:303-308
71. Talaulikar D, Dahlstrom JE, Shadbolt B, Broomfield A, McDonald A, Pidcock M (2008) Role of immunohistochemistry in staging diffuse large B-cell lymphoma (DLBCL). J Histochem Cytochem (in press)
72. Odenthal M, Siebolts U, Ernestus K, Disse D, Dienes HP, Wickenhauser C (2008) Immunoglobulin heavy chain gene analysis in bone marrow biopsies and corresponding lymph node specimens: dependency on pre-treatment, histological subtype and extension of B-cell lymphoma. Int J Mol Med 21:569-576
73. Weinberg OK, Seo K, Arber DA (2008) Prevalence of bone marrow involvement in systemic anaplastic large cell lymphoma: are immunohistochemical studies necessary? Hum Pathol (in press)
74. Böttcher S, Ritgen M, Buske S, Gesk S, Klapper W, Hoster E, Hiddemann W, Unterhalt M, Dreyling M, Siebert R, Kneba M, Pott C (2008) Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations. EU MCL MRD Group Haematologica 93:551-559
75. Rezanko T, Sucu HK, Akkalp A, Tunakan M, Sari A, Minoglu M, Bolat B (2008) It is possible to start the treatment based on immediate cytologic evaluation of core needle biopsy of the spinal lesions? Diagn Cytopathol 36:478-484
76. Kost CB, Holden JT, Mann KP (2008) Marginal zone B-cell lymphoma: a retrospective immunophenotypic analysis. Cytometry B Clin Cytom (in press)
77. Nguyen AN, De J, Nguyen J, Padula A, Qu Z (2008) A teaching database for diagnosis of hematologic neoplasms using immunophenotyping by flow cytometry. Arch Pathol Lab Med 132:829-837
78. Langerak AW, Molina TJ, Lavender FL, Pearson D, Flohr T, Sambade C, Schuuring E, Al Saati T, van Dongen JJ, van Krieken JH (2007) Polymerase chain reaction-based clonality testing in tissue samples with reactive lymphoproliferations: usefulness and pitfalls. A report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 21(2):222-9
79. Chute DJ, Cousar JB, Mahadevan MS, Siegrist KA, Silverman LM, Stoler MH (2008) Detection of immunoglobulin heavy chain gene rearrangements in classic Hodgkin lymphoma using commercially available BIOMED-2 primers. Diagn Mol Pathol 17:65-72